Targeting tumor‐associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Tumor-associated fibroblasts are key regulators of tumorigenesis. In contrast to tumor cells, which are genetically unstable and mutate frequently, the presence of genetically more stable fibroblasts in the tumor-stromal compartment makes them an optimal target for cancer immunotherapy. These cells are also the primary source of collagen type I, which contributes to decreased chemotherapeutic drug uptake in tumors and plays a significant role in regulating tumor sensitivity to a variety of chemotherapies. To specifically kill tumor-associated fibroblasts, we constructed an oral DNA vaccine targeting fibroblast activation protein (FAP), which is specifically overexpressed by fibroblasts in the tumor stroma. Through CD8+ T cell-mediated killing of tumor-associated fibroblasts, our vaccine successfully suppressed primary tumor cell growth and metastasis of multidrug-resistant murine colon and breast carcinoma. Furthermore, tumor tissue of FAP-vaccinated mice revealed markedly decreased collagen type I expression and up to 70% greater uptake of chemotherapeutic drugs. Most importantly, pFap-vaccinated mice treated with chemotherapy showed a 3-fold prolongation in lifespan and marked suppression of tumor growth, with 50% of the animals completely rejecting a tumor cell challenge. This strategy opens a new venue for the combination of immuno- and chemotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, depleting fibroblast activation protein (FAP)+ CAFs via a FAP vaccine decreases collagen density and improves chemoresistance in mouse models [99].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Stromal Effects on Mammary Gland Development and Breast Cancer
Wiseman, B. S., & Werb, Z. (2002) · Science · doi:10.1126/science.1067431 · Cited by 923
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection
Baxter, L. T., & Jain, R. K. (1989) · Microvascular Research · doi:10.1016/0026-2862(89)90074-5 · Cited by 894
Cited by
Items 501–600 of 648
Cancer-associated fibroblasts in neoadjuvant setting for solid cancers
Gu, Y., Chen, Q., Yin, H., Zeng, M., Gao, S., & Wang, X. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104226 · Cited by 8
Cardascia, N., Pastore, V., Bini, V., Tegola, M. G. L., & Alessio, G. (2020) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 7
Zhao, T., Zhou, H., Wu, W., Song, X., & Gong, T. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1879831 · Cited by 7
“Tumors were weighed and the TGI was calculated by the following equation: TGI 1⁄4 (1 (Mean tumor weight of treatment group)/(Mean tumor weight of control group)) 100% [41,42].”
MethodHsu, C., Ahmed, A. T., Rab, S. O., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Nathiya, D., Kariem, M., & KADHIM, A. J. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114424 · Cited by 11
Mass Spectrometry Imaging of Fibroblasts: Promise and Challenge
Angel, P. M., Rujchanarong, D., Pippin, S., Spruill, L., & Drake, R. R. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1941893 · Cited by 6
Tian, G., Zhang, J., Bao, Y., Li, Q., & Hou, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110984 · Cited by 6
Liu, Y., Han, X.-L., Han, Y., Bi, J., Wu, Y., Xiang, D., Zhang, Y., Bi, W., Xu, M., & Li, J. (2024) · Gene · doi:10.1016/j.gene.2024.148286 · Cited by 7
Lan, H., Yan, W., Huang, X., Cui, J., & Hou, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1545762 · Cited by 6
Cotter, M. B., & Loda, M. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_3 · Cited by 6
Dipeptidyl Peptidase-IV and Related Proteases in Brain Tumors
Bušek, P., & Šedo, A. (2013) · InTech eBooks · doi:10.5772/53888 · Cited by 6
“Further, induction of immune response against FAP leads to a decreased tu‐ mor growth and an enhanced effect of cytostatic therapy in several experimental models [239-242].”
Fan, M., Guo, X., Liu, G., Tian, C., Zhao, J., & Chen, Y. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006210 · Cited by 5
Rossetti, M., Stanca, S., Frate, R. D., Bartoli, F., Marciano, A., Esposito, E., Fantoni, A., Erba, A. P., Lippolis, P. V., & Faviana, P. (2023) · Diagnostics · doi:10.3390/diagnostics13203199 · Cited by 5
“This study serves as a groundwork for future research that could integrate immunohistochemical data with advanced imaging techniques like PET/CT for improved CRC management.”
BackgroundHuang, L.-T., Tsai, C.-L., Huang, S.-H., Chang, M., Chang, W., Cheng, L.-H., & Cheng, H.-C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218272 · Cited by 6
“Consistently, CAFs has currently been reported to be indeed activated in renal cell carcinoma (RCC) with VHL gene malfunction in which RCC cells are deficient in assembling periFN matrices [57].”
BackgroundInfluentialTadeo, I., Álvaro, T., Navarro, S., & Noguera, R. (2016) · InTech eBooks · doi:10.5772/62479 · Cited by 6
Modeling the effect of acquired resistance on cancer therapy outcomes
Masud, M. A., Kim, J., & Kim, E. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107035 · Cited by 5
Phankeaw, P., Khanaruksombat, S., Numprasit, W., Jamjuntra, P., Augsornworawat, P., Warnnissorn, M., Thuwajit, P., & Thuwajit, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-28439-y · Cited by 4
“The cancer-associated fibroblasts (CAFs), the most abundant cells in TME, are indicated by an overexpressed fibroblast activation protein (FAP) and correlated with poor prognosis 19 .”
Kashyap, D., Bhattacharya, S., Irinike, S., Khare, S., Das, A., Singh, G., & Bal, A. (2024) · Breast Disease · doi:10.3233/bd-230011 · Cited by 4
Molecular Targets and Nano-Technological Approaches in the Treatment of Hepatic Carcinoma
Satapathy, T., & Diwakar, M. K. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096336494240915164019 · Cited by 5
Saravanan, G., Muruganantham, B., Hirad, A. H., Alarfaj, A. A., Thangavelu, I., Arulselvan, P., Jaganathan, R., Ravindran, R., Suriyaprakash, J., & Boopathi, T. S. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2689 · Cited by 4
Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction
Ren, J., Lu, X., Griffiths, R., Privratsky, J. R., & Crowley, S. D. (2021) · Kidney360 · doi:10.34067/kid.0007182020 · Cited by 4
“Analogously cytotoxic CD8 T cells can limit cancer growth by killing tumor-associated fibroblasts (35, 36).”
Background[Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
Huang, C., Xu, J., & Li, Z. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.102.16 · Cited by 4
Rijal, G. (2021) · Bioengineering · doi:10.3390/bioengineering8110163 · Cited by 4
Köhler, N., & Zeiser, R. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_261-1 · Cited by 4
Fibroblast Activation Protein Inhibitor Theranostics
Raju, S., Shukla, J., & Kumar, R. (2022) · PET Clinics · doi:10.1016/j.cpet.2022.03.005 · Cited by 4
Factors affecting heterogeneity in breast cancer microenvironment: A narrative mini review
Ganguly, A., Mukherjee, S., Chatterjee, K., & Spada, S. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.01.002 · Cited by 4
Latest Therapeutic Approaches Based on Cancer Stem Cells
Dou, J., Wang, J., & Gu, N. (2011) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/17256 · Cited by 4
Nuklearmedizinische Theranostik: Update Nuklearmedizin 2021
Eiber, M., Kratochwil, C., Lapa, C., & Brenner, W. (2021) · Der Onkologe · doi:10.1007/s00761-021-00956-1 · Cited by 4
“a) Die Subpopulation der FAP-positiven tumorassoziierten Fibroblasten spielt eine Schlüsselrolle für die Produktion der extrazellulären Matrix, welche zu einer erhöhtenGewebesteifheit, konsekutiv einem höheren intramuralen Druck und dadurch einer geringeren Diffusion von Chemotherapeutika in den Tumor führt [30].”
BackgroundCancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy
Nilforoushan, N., Khavaran, A., Palihati, M., Patel, Y., Giarratana, A. O., Das, J. P., & Capaccione, K. M. (2025) · Tomography · doi:10.3390/tomography11120143 · Cited by 4
“They have also been studied in multidrug-resistant murine colon and breast carcinoma [160].”
Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
Valcz, G., Sípos, F., Tulassay, Z., Molnar, B. A., & Yagi, Y. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-202561rep · Cited by 3
Intratumoral Fibrosis: Emerging Concepts and Therapeutic Opportunities
Cremasco, V., & Chang, J. J. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00259 · Cited by 4
Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors
Yoshikawa, T., Phan, K. Q., Tagawa, H., Sasaki, K., Feng, H., Kishimura, A., Mori, T., & Katayama, Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119352 · Cited by 5
Park, R., Chatterjee, D., Amin, M. A., & Trikalinos, N. A. (2020) · Current Problems in Cancer Case Reports · doi:10.1016/j.cpccr.2020.100037 · Cited by 3
de Souza, J. C., Junior, R. S. R., Pimenta, T. M., Martins, B. D. S., & Rangel, L. B. A. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.91 · Cited by 6
Zhang, G., Tai, P., Fang, J., Wang, Z., Yu, R., Yin, Z., & Cao, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34526 · Cited by 4
“Since there are no fibroblasts in the brain, it has not been clear whether fibroblasts exist in ADHGG for a long time [18].”
Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis
Valdivia‐Silva, J., & Chinney-Herrera, A. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.07.002 · Cited by 3
Novel Insights Into the Role of Inflammation in Promoting Breast Cancer Development
Valdivia‐Silva, J., Franco‐Barraza, J., Cukierman, E., & Garcia-Zepe, E. A. (2011) · InTech eBooks · doi:10.5772/21699 · Cited by 3
“In fact, antibodies against fibroblast activation protein induced a marked decrease in desmoplastic collagen I expression resulting in an increased (up to 70%) increment in chemotherapeutic drugs uptake (Loeffler et al., 2006).”
The Cellular Microenvironment of Head and Neck Squamous Cell Carcinoma
Mathew, M., & Mary, S. (2012) · InTech eBooks · doi:10.5772/25652 · Cited by 3
“Specific targeting of TAFs with CD8+ T-cells resulted in reduced growth and metastasis of colon and breast tumors [23].”
BackgroundLi, Y., Di, X., Chen, J., Wei, J., Li, T., Wang, K., Liao, B., & Luo, D. (2025) · MedComm – Oncology · doi:10.1002/mog2.70048 · Cited by 6
Targeting fibroblast activation protein-α to treat renal fibrosis
Gong, L., Lu, X., Ma, N., Lu, T., Gong, Y., Hao, L., Xu, W., Zhang, Q., Chen, X., Mo, Q., et al. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00898-9 · Cited by 4
Targeting cancer-associated fibroblasts in immunotherapy
Kim, D., Wu, Y., & Oh, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00007-5 · Cited by 3
Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy
Kasperska, A., Borowczak, J., Szczerbowski, K., Stec, E., Ahmadi, N., & Szylber, Ł. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210825101456 · Cited by 2
Yingshu, 崔. C., Yi, 李. L., & Xiaosong, 李. L. (2024) · Chinese Journal of Lasers · doi:10.3788/cjl231388 · Cited by 2
Sato, A., Takagi, K., Yoshida, M., Yamaguchi, M., Sagehashi, M., Miki, Y., Miyashita, M., & Suzuki, T. (2024) · Cancers · doi:10.3390/cancers16244285 · Cited by 3
Targeting Colon Drug Delivery by Natural Products
Kim, H. (2012) · InTech eBooks · doi:10.5772/52346 · Cited by 2
Kim, J., Yu, J.-M., Bae, Y.-C., & Jung, J.-S. (2011) · Journal of Life Science · doi:10.5352/jls.2011.21.5.631 · Cited by 2
“Recently, the significance of targeting CAFs in cancer therapy has been increasingly emphasized in many reports [29,32].”
BackgroundDeepika, G., Reddy, G., Brahmaiah, V., Kavitha, B., Nethagani, J., Palaparthi, E., & Lebaka, R. (2023) · Archives of Medicine and Health Sciences · doi:10.4103/2321-4848.379062 · Cited by 4
Wan, S., Liang, Z., Yao, S., Wang, A., Liu, X., He, H., Cai, H., Gao, Y., & Wang, H. (2024) · Aging · doi:10.18632/aging.205997 · Cited by 2
Tumor-Stromal Interactions in Invasion and Metastases
Erkan, M., Esposito, I., Friess, H., & Kleeff, J. H. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_23 · Cited by 3
Zhang, M., & Rosen, J. M. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200005 · Cited by 2
Hernández-Hidalgo, N., Cortes, G., Ortega-Anaya, K., & Varela, H. (2024) · World Journal of Meta-Analysis · doi:10.13105/wjma.v12.i4.95755 · Cited by 1
Liu, Y., Zhao, T., Shi, R., Xie, Y., Li, M., & Wang, Y. (2026) · Seminars in Oncology · doi:10.1016/j.seminoncol.2026.152483 · Cited by 1
Wang, S. Q., Wang, D., Zhou, Y.-N., Li, W., Sun, G., Cao, L., Feng, C., Chen, Y., Shao, C., Gui, Q., et al. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00783-3 · Cited by 1
“FAP-targeted therapies include small molecule inhibitors [225], antibodies [226], DNA vaccines [227], and nanoparticles [228, 229].”
Tian, X., Wang, L., He, C., Teng, Y., Zhang, Y., Cui, Z., & Liu, J. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00029 · Cited by 1
Therapeutical Cues from the Tumor Microenvironment
Marastoni, S., Andreuzzi, E., Colladel, R., Paulitti, A., Silvestri, A., Todaro, F., Colombatti, A., & Mongiat, M. (2011) · InTech eBooks · doi:10.5772/24796 · Cited by 1
Fibroblast Activation Protein (FAP): A Key Modulator of the Cancer Microenvironment
Mousavi, M. J., Karami, J., Alimohammadi, M., Solaymani‐Mohammadi, F., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_357-1 · Cited by 1
Cancer Stem Cells (CSCs) in Tumor Ecosystem
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_17 · Cited by 2
Molecular Relationships Between Chronic Pancreatitis and Cancer
Logsdon, C. D., Ji, B., & Hwang, R. F. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_11 · Cited by 2
The Response of Cancer Cell Populations to Therapies
Lindsay, D., Garvey, C. M., Mumenthaler, S. M., & Foo, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804310-3.00010-7 · Cited by 1
Ganesan, S., Upadhye, V. J., Aulakh, D., Bishnoi, S., Chinnathambi, A., Alahmadi, T. A., Abudoleh, S. M., Arulselvan, P., & Thangavelu, I. (2024) · Journal of Applied Polymer Science · doi:10.1002/app.56262 · Cited by 1
Cancer in Context: Importance of the Tumor Microenvironment
Fingleton, B., & Lynch, C. C. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0814-8_3 · Cited by 1
Microvesicular Transfer of MicroRNA in Tumor Microenvironment
Vallabhaneni, K. C., Penfornis, P., Orr, J. G., Chauhan, K. M., & Pochampally, R. R. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8065-6_17 · Cited by 1
Palliyage, G. H. (2023) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12138 · Cited by 1
Schillings, L., Röhrich, M., Heger, U., Gutjahr, E., Spektor, A.-M., Büchler, M. W., & Hackert, T. (2026) · Research Square · doi:10.21203/rs.3.rs-9213048/v1 · Cited by 1
ROLE OF CXCL1 SIGNALING IN STROMA: EPITHELIUM INTERACTIONS DURING BREAST CANCER PROGRESSION
Zou, A. (2014) · KU ScholarWorks (The University of Kansas)
Jakobs, M. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14453
Regulation of Breast Cancer Stem Cell by Tissue Rigidity
Engler, A. J., Yang, J., Wei, S. C., Fattet, L., & Ondeck, M. G. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada609393
Hutchinson, E. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1959
Targeting Cancer Associated Fibroblasts for Cancer Immunotherapy
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.80
“FAP-specific T cells can be activated in humans ex vivo [47] and two groups of investigators have shown in preclinical animal models that DNA or DC FAP vaccines had antitumor effects in several murine models, including melanoma, thymoma, and metastatic breast cancer ([48-51]).”
BackgroundVascular homeostasis: insights from a fibrotic mouse
Santoro, S. P., & Maas, N. L. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006726
“Numerous studies have demonstrated that collagen, the most abundant protein of the extracellular matrix, plays an important role in regulating vessel permeability (Brown et al., 2003; Loeffler et al., 2006).”
BackgroundHägglöf, C. (2010) · Figshare
Mobilization of Adipose Stromal Cells in Obesity and Cancer by SPARC and its Proteolytic Isoforms
Tseng, C. (2015) · Digital Commons-TMC (Texas Medical Center)
Mathonnet, M., Perraud, A., Blondy, S., Christou, N., Akil, H., Battu, S., & Jauberteau, M. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-21702-4_9
Glyco-profiling of bladder cancer stem cells based on chemotherapy sorting approach
Parreira, B. S. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/trk8-bt67
Targeting Tumor Associated Fibroblasts and Chemotherapy
Liao, D., & Reisfeld, R. A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0659-0_21
“We have shown that oral vaccination of mice with doubly attenuated RE88 S. typhimurium transduced with full-length cDNA encoding murine FAP (pFAP), elicits a specific host cellular immune response against FAP-expressing CAFs ( Loeffler et al. 2006 ).”
BackgroundInfluentialFormation and Regulation of niche for cancer stem cells
Takakura, N. (2012) · Drug Delivery System · doi:10.2745/dds.27.28
Dipeptidyl Peptidases: Substrates and Therapeutic Targeting in Human Health and Disease
Wilson, C. H., & Abbott, C. A. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733151-00001
Wang, T., Yun, S. J., & Xu, X. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_1 · Cited by 1
Rôle d’ICAM-1 dans le remodelage de la matrice extracelllulaire par les fibroblastes tumoraux
Bonan, S. (2016) · theses.fr (ABES) · doi:10.70675/94af1f27z43b1z4b44za27az33acbc56f275
Anand, P. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/70579
iTRAQ-based Quantitative Proteomic Analysis of Mammalian Cell Lines
Talebian, V. (2018) · UWSpace (University of Waterloo)
Extracellular matrix modifications by oligoguluronates for cancer treatment
Haug, B. (2018) · NORA - Norwegian Open Research Archives
Jung, Y. H., Park, H., Na, K., Kim, H., Yang, J., & Chung, S. H. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012683-00294
MECHANICAL REGULATION OF GENOMIC INSTABILITY IN CANCER
Simi, A. K. (2018)
THE ROLE OF THE TUMOR MICROENVIRONMENT IN WALDENSTRÖM MACROGLOBULINEMIA
Han, W. (2019) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Exploring the roles of the Protein Kinase N family in breast cancer
Baskaran, P. (2018) · Queen Mary Research Online (Queen Mary University of London)
Enhancing Anti-Cancer Properties of Human Natural Killer Cells
Fitzgerald, A. A. (2021) · DigitalGeorgetown (Georgetown University Library)
Chung, L., Franch, X., & Maiden, N. (2005)
Targeting JAK/STAT signalling for sensitization of colorectal cancer cells to chemoradiotherapy
Koerdel, K. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8719
Huang, Y. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.7184956.7426054
Adipose Tissue-Derived Progenitor Cells and Cancer
Tseng, C., & Kolonin, M. G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8069-3_15
Loi, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732540149.793562857
Zhao, H., & Zhu, X. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717996667.793474070
Rinelda, Y., Wresnindyatsih, & Farida, A. (2021) · Majalah Patologi Indonesia · doi:10.55816/mpi.v30i2.468
Data from Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma
Zhang, B., Zhang, Y., Bowerman, N. A., Schietinger, A., Fu, Y., Kranz, D. M., Rowley, D. A., & Schreiber, H. W. (2023) · doi:10.1158/0008-5472.c.6497487
18F-AlF-FAPI nanotracer visualized the quick response of sarcoma to radiotherapy by PET/CTPreprint
Li, Z., Ren, C., Liu, M., Zhang, J., Zhang, J., Qi, M., Xue, Y., Xu, X., Yao, A., Song, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3113339/v1
Huang, R., Ding, J., & Xie, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00017-6
O’Fee, K., Burley, A., & Wilkins, A. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00005-9
Metadata
- Authors
- Loeffler, M.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Loeffler, M.
- ORCID
- Loeffler, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1955-1962
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1481657
- OpenAlex
- W2002689409
- Cited by
- 633
- References
- 51
- Citations by year
- 2026: 17 · 2025: 27 · 2024: 41 · 2023: 58 · 2022: 33 · 2021: 56 · 2020: 43 · 2019: 39 · 2018: 28 · 2017: 32 · 2016: 39 · 2015: 46 · 2014: 33 · 2013: 33 · 2012: 28
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- National Cancer Institute (CA 83856, R01CA083856)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer-associated fibroblasts, fibroblast activation protein, oral DNA vaccine, type I collagen, tumor stroma, chemosensitization, multidrug resistance, colon cancer, breast cancer, metastasis, chemoimmunotherapy
- MeSH terms
- Fibroblast Activation Protein Alpha, Animals, Female, Fibroblasts, Membrane Proteins, Mice, Inbred BALB C, Neoplasms, Endopeptidases, Recombinant Fusion Proteins, Serine Endopeptidases, Survival Rate, Gelatinases, CD8-Positive T-Lymphocytes, Vaccines, DNA, Cancer Vaccines, Collagen Type I, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.